Clinical Trial Update: To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study evaluating the safety and efficacy of KX-826 in Chinese female subjects with androgenetic alo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• KX-826

Snippet

Sponsor: Suzhou Koshine Biomedica, Inc. | Conditions: Alopecia | Phase 2 | Status: COMPLETED